Consequently, extensive scientific literature attests that a number of human tumors, such as non-small cell lung cancer, squamous cell carcinoma of the head and neck, glioblastoma, pancreatic cancer, ovarian cancer, breast cancer, and prostate cancer, are intricately associated with the overactivation of the human epidermal growth factor receptor 2 (Her2), which belongs to the ErbB (erythroblastic oncogene B) protein tyrosine kinase subfamily [30,108,112,113]. Here, ERBB2 is linked to breast cancer.